Ledaborbactam Etzadroxil
- Generic Name
- Ledaborbactam Etzadroxil
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
Phase 1
Active, not recruiting
- Conditions
- Healthy VolunteerPharmacokineticsSafetyDrug-Drug Interaction (DDI)FDC
- Interventions
- Drug: Ceftibuten-ledaborbactam etzadroxil
- First Posted Date
- 2024-12-13
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT06733675
- Locations
- 🇺🇸
ICON, Clinical Research Phase I Unit, Lenexa, Kansas, United States
Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Phase 1
Completed
- Conditions
- PharmacokineticsHealthy Volunteers
- Interventions
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Venatorx Pharmaceuticals, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT06665555
- Locations
- 🇺🇸
Pulmonary Associates, Phoenix, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath